CARE Ratings reschedules analyst meet to June 29
CARE Ratings has rescheduled its virtual analyst and institutional investor meet with Millingtonia Capital from June 25, 2026, to June 29, 2026, at 12:00 PM IST due to exigencies. The meeting will focus on the company's performance and outlook based on publicly available information, and no unpublished price sensitive information will be shared. The investor presentation for Q4 and FY26 is available on the company's website.

*this image is generated using AI for illustrative purposes only.
CARE Ratings has rescheduled its virtual analyst and institutional investor meet with Millingtonia Capital to June 29, 2026, at 12:00 PM IST due to exigencies. The meeting, originally set for June 25, 2026, at 02:00 PM IST, will discuss the company's performance and outlook based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule may undergo changes due to exigencies on the part of the participants or the company.
The investor presentation covering Q4 and FY26 has been made available on the official website of CARE Ratings Limited. Manoj Kumar CV, Company Secretary & Compliance Officer, signed the intimation on June 25, 2026.
Meeting Schedule
| Sr.No. | Fund/Research House | Date of Meeting/Event | Time | Type of Event/Meeting |
|---|---|---|---|---|
| 1 | Millingtonia Capital | 29 June 2026 | 12:00 PM | Virtual |
Historical Stock Returns for CARE Ratings
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.61% | -0.61% | +4.21% | +3.59% | -8.63% | +140.56% |
What specific exigencies led to the rescheduling of the meeting with Millingtonia Capital?
How might the delay impact investor sentiment or market perception of CARE Ratings?
Will the rescheduling affect the timing or content of the Q4 and FY26 investor presentation?































